Biogen Inc. (SNSE:BIIB)

Biogen Ratios and Metrics

Market cap in millions CLP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	24,890,619	23,256,200	22,143,462	32,872,491	33,877,394	30,026,610
Market Cap Growth	20.87%	5.03%	-32.64%	-2.97%	12.83%	12.16%
Enterprise Value	26,980,089	25,624,954	27,064,065	37,626,977	34,602,825	33,560,450
Last Close Price	156979.02	163093.42	243461.40	214793.95	208139.75	208740.00
PE Ratio	21.37	19.97	13.65	32.29	13.09	22.65
PS Ratio	2.79	2.61	2.30	3.81	3.92	3.21
PB Ratio	1.51	1.41	1.33	2.53	2.98	3.22
P/TBV Ratio	10.68	9.98	40.82	172.63	6.88	12.10
P/FCF Ratio	13.47	12.59	8.19	29.52	34.86	10.42
P/OCF Ratio	12.53	11.71	7.75	24.23	28.81	9.68
EV/Sales Ratio	3.15	2.88	2.82	4.36	4.00	3.59
EV/EBITDA Ratio	8.35	7.89	8.41	17.93	11.52	10.04
EV/EBIT Ratio	11.02	10.07	10.62	22.60	13.49	11.47
EV/FCF Ratio	14.61	13.87	10.01	33.79	35.60	11.65
Debt / Equity Ratio	0.37	0.37	0.40	0.50	0.50	0.70
Debt / EBITDA Ratio	1.79	1.79	2.00	2.93	1.85	1.91
Debt / FCF Ratio	3.25	3.25	2.47	5.85	5.87	2.28
Net Debt / Equity Ratio	0.13	0.13	0.26	0.43	0.08	0.27
Net Debt / EBITDA Ratio	0.67	0.67	1.34	2.67	0.32	0.76
Net Debt / FCF Ratio	1.18	1.18	1.60	5.02	0.97	0.89
Asset Turnover	0.34	0.34	0.35	0.38	0.42	0.45
Inventory Turnover	0.90	0.90	0.85	1.31	1.69	1.74
Quick Ratio	1.70	1.70	0.77	1.04	2.39	1.34
Current Ratio	2.68	2.68	1.35	2.00	2.99	1.83
Return on Equity (ROE)	7.39%	7.39%	10.36%	8.24%	24.33%	15.96%
Return on Assets (ROA)	6.14%	6.14%	5.84%	4.62%	7.79%	8.86%
Return on Invested Capital (ROIC)	11.19%	11.13%	10.40%	9.35%	16.55%	21.63%
Return on Capital Employed (ROCE)	10.80%	10.80%	11.40%	8.10%	14.20%	17.50%
Earnings Yield	4.68%	5.01%	7.32%	3.10%	7.64%	4.42%
FCF Yield	7.42%	7.94%	12.21%	3.39%	2.87%	9.60%
Buyback Yield / Dilution	-0.82%	-0.82%	-0.21%	0.27%	2.41%	7.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.